| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,877 |
2,393 |
$155K |
| S9083 |
Global fee urgent care centers |
873 |
786 |
$114K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
858 |
781 |
$56K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,878 |
1,563 |
$25K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
326 |
300 |
$19K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
150 |
115 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,523 |
1,050 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
100 |
96 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
903 |
739 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
68 |
60 |
$708.28 |
| 0012A |
|
12 |
12 |
$600.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$364.91 |
| 87807 |
|
55 |
51 |
$230.56 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
74 |
62 |
$160.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
158 |
130 |
$64.32 |
| 81003 |
|
32 |
28 |
$35.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
968 |
615 |
$13.27 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
169 |
158 |
$0.00 |
| 91301 |
|
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
80 |
62 |
$0.00 |